MATERNUS-Kliniken-AG
XETRA:MAK

Watchlist Manager
MATERNUS-Kliniken-AG Logo
MATERNUS-Kliniken-AG
XETRA:MAK
Watchlist
Price: 1.23 EUR -4.65% Market Closed
Market Cap: 25.8m EUR

Intrinsic Value

The intrinsic value of one MAK stock under the Base Case scenario is 10.48 EUR. Compared to the current market price of 1.23 EUR, MATERNUS-Kliniken-AG is Undervalued by 88%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MAK Intrinsic Value
10.48 EUR
Undervaluation 88%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
MATERNUS-Kliniken-AG

MAK
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MAK cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

MATERNUS-Kliniken-AG
XETRA:MAK
DE
Health Care
Market Cap
25.8m EUR
IPO
Apr 2, 1997
DE
Health Care
Market Cap
25.8m EUR
IPO
Apr 2, 1997
Price
false
EPS
false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MAK?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about MATERNUS-Kliniken-AG
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
MATERNUS-Kliniken-AG

Current Assets 22.3m
Cash & Short-Term Investments 9.6m
Receivables 11.7m
Other Current Assets 995k
Non-Current Assets 128.3m
Long-Term Investments 979k
PP&E 114.1m
Intangibles 13.2m
Other Non-Current Assets -1k
Efficiency

Free Cash Flow Analysis
MATERNUS-Kliniken-AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
MATERNUS-Kliniken-AG

Revenue
159.4m EUR
Cost of Revenue
-21.7m EUR
Gross Profit
137.8m EUR
Operating Expenses
-140.9m EUR
Operating Income
-3.1m EUR
Other Expenses
-13m EUR
Net Income
-16.1m EUR
Fundamental Scores

MAK Profitability Score
Profitability Due Diligence

MATERNUS-Kliniken-AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
Positive Free Cash Flow
53/100
Profitability
Score

MATERNUS-Kliniken-AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

MAK Solvency Score
Solvency Due Diligence

MATERNUS-Kliniken-AG's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
22/100
Solvency
Score

MATERNUS-Kliniken-AG's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MAK Price Targets Summary
MATERNUS-Kliniken-AG

There are no price targets for MAK.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MAK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one MAK stock?

The intrinsic value of one MAK stock under the Base Case scenario is 10.48 EUR.

Is MAK stock undervalued or overvalued?

Compared to the current market price of 1.23 EUR, MATERNUS-Kliniken-AG is Undervalued by 88%.

Back to Top